Back to Treatments

Treatment

Cisplatin + Paclitaxel + Bevacizumab

1
Conditions
35
Trials
5,000
Participants
25%
Average Safety

Condition Evidence

Cervical cancer

35 trials · 5,000 participants

50% effectiveness · 25% safety
Cisplatin + Paclitaxel + Bevacizumab | DFDA